SB 511 — AN ACT CONCERNING OPIOIDS.

General Assembly   RaisedSubstitute Bill No.

511 February Session, 2018   LCO*_____SB00511PH____032718____* No.AN ACT CONCERNING OPIOIDS.

2291   *02291_______PH_* Referred to Committee on PUBLIC HEALTH   Introduced by:

  (PH)   AN ACT CONCERNING OPIOIDS.

SuchThe working group shall consist of the Commissioner of Mental Health and Addiction Services, or the commissioner's designee, the Chief Medical Examiner, or the Chief Medical Examiner's designee, the Insurance Commissioner, or the commissioner's designee, and at least eight other members selected by the Commissioner of Mental Health and Addiction Services, who have experience in one or more of the following:

(4) Whether a nonfatal drug overdose at a hospital or outpatient surgical facility should qualify as an adverse event under section 19a-127n of the general statutes;

and (5) The role of health carriers, as defined in section 19a-755b of the general statutes, in shortening a person's stay at a treatment program for persons with substance use disorder.disorder;

(c)(6) OnThe oravailability beforeof Januaryfederal 1,funds 2019,to supply emergency medical services personnel in the workingstate groupwith shallopioid reportantagonists itsand findingsprovide training to thesuch Commissionerpersonnel ofin Mentalthe Healthadministration andof Addictionopioid Services.antagonists;

and (7) The development and implementation of a state-wide uniform prehospital data reporting system to capture the demographics of prehospital administration or use of an opioid antagonist and opioid reversal outcomes as a result of such administration or use.

(c) On or before January 1, 2019, the chairperson of the working group shall report the findings of the working group to the Commissioner of Mental Health and Addiction Services.

(11) Prior to dispensing an opioid drug, as defined in section 20-14o, to any patient, the pharmacist shall review the patient's record in the electronic prescription drug monitoring establishedprogram pursuant to this subsection for purposes related to the scope of the pharmacist's practice and management of the patient's drug therapy, including the monitoring of controlled substances obtained by the patient.

(NEW) (Effective July 1, 2018) (a) Any hospital, emergency medical services provider, health care provider or mental health care professional who treats a patient for an overdose of an opioid drug, as defined in section 20-14o of the general statutes, shallshall, subject to the limitation set forth in subsection (b) of this section, report such overdose to the municipal health department or district department of health that has jurisdiction over the location in which such overdose occurred or, if such location is unknown, the location in which such provider treated such patient.

4 July 1, 2018 New section StatementPH ofJoint Purpose:Favorable Subst.

To evaluate and establish methods of combating the opioid crisis in the state.

[Proposed deletions are enclosed in brackets.

Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]